Europe to ban direct-to-consumer genetic tests?

FDA to regulate direct-to-consumer genetic tests.

began, genetic tests were available for about 100 diseases — most of them caused by just one faulty gene, such as the mutations that cause Tay-Sachs and cystic fi brosis. As genomic technologies matured and sequencing became less costly, companies began developing tests for a wider range of complex, multigenic, common diseases. These were initially offered by laboratories used by physicians, bu...

The regulation of direct-to-consumer genetic tests.

The past year has been marked by the emergence of several companies, such as 23andMe, deCODEME, Navigenics and Knome, offering tests using genome-wide technology direct to consumers over the internet. On the basis of the published research findings of GWAS and other studies, these companies will calculate an individual's risk to a number of common diseases, without the necessity of going throug...

Direct-to-Consumer Genetic Testing: Interdisciplinary Crossroads

Yes Vote Message: a cohort receives a VOTE REQ, and it responds by sending a yes or no vote message (Yes or NO VOTE, Yes Vote also known as PREPARED message) to the coordinator (Shanker, Misra, & Sarje, 2009a) Yet Another Workflow Language (YAWL): a process modelling and execution language based on the workflow patterns and Petri nets. YAWL is also the name of the corresponding workflow system ...

Direct-to-consumer genetic testing: driving choice?

Direct-to-consumer genetic testing (DTCGT), which includes both the advertising and offer of genetic tests directly to the public [1], existed for many years before the, now famous, companies such as deCODE and 23andme made their appearance on the market [2]. However, the sharp increase in companies offering DTC-GT over the last 3 years has sparked much regulatory and ethical debate [3–5]. The ...

Direct-to-consumer marketing for genetic testing.